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Abstract 
This paper outlines the development and implementation of Medi SPICE-Adept. Medi SPICE-Adept is 
a lightweight assessment method that has been designed for usage with the Medi SPICE software 
process assessment and improvement model which is currently being developed for the medical 
device industry.  While the Medi SPICE model is detailed and comprehensive in its approach there is 
industry demand for a lightweight medical device process assessment and improvement method. To 
address this requirement Medi SPICE-Adept has been developed. Details on how this has taken place 
and the procedures for implementing a Medi SPICE-Adept assessment are presented.  Information is 
also provided regarding how a Medi SPICE-Adept assessment was undertaken in an Irish based 
medical device company.  A summary of the issues identified from this assessment and the actions 
taken to facilitate process improvement is also presented. Finally, plans for future work are 
discussed. 
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1 Introduction 
Due to the potential threat that medical devices can pose to patients, clinicians and third parties 
their development is highly regulated.   In recent years there has been a significant increase in the 
role and importance that software plays in the healthcare industry [1].  The outcome of this has 
been the functionality, complexity and size of software components in medical devices has  
substantially increased [2].  This development has been recognized by the European Union (EU) in 
their latest amendment to the Medical Device Directive (MDD) (2007/47/EC) [3].  As a result 
standalone software can now be classified as an active medical device in its own right in the EU.   
Given the importance and relevance of this measure the European Commission released a guidance 
document  for the qualification and classification of standalone medical device  software MEDDEV 
2.1/ [4] in January 2012. In the United States (US) the Food and Drug Administration (FDA) is 
responsible for the regulation and approval of medical devices and has published software specific 
guidance documents for medical device software developers. These are the General Principals of 
Software Validation [5],  Off the Shelf Software Use in Medical Devices [6] and Guidance on the 
Content of Premarket Submissions for Software Contained in Medical Devices [7].   To address the 
increasingly important role that software  now plays the FDA recently published  the Medical Device 
Data Systems Final Rule [8] and Draft Guidance in Relation to Mobile Applications [9].    
 
Given the mission critical nature of medical device software compliance with the relevant 
regulations, and international standards of the location where a medical device is to be marketed is 
obligatory [10]. In the EU the receipt of the CE mark is essential and in the US FDA approval is 
required. There are approval bodies performing similar roles in other countries including China, 
Canada, India, Japan, and Australia.  A key international standard for achieving regulatory 
compliance is IEC 62304:2006 [11] and its aligned standards ISO13485:2003 [12],  ISO 14971:2007 
[13], EN 60601-4:2000 [14],  IEC 62366:2007 [15], and IEC 60812:2006 [16]. Information is also 
provided in the technical report  IEC/TR 80002-1:2009 [17] and IEC 61508:2010 [18].  Despite the 
provision of these international standards, regulations and guidance documents the information 
they offer is high-level and no specific methods for performing the essential activities required have 
been provided [19].   
 
It is therefore not surprising given the importance that achieving regulatory approval plays that 
organisations developing medical device software have focused on achieving compliance rather than 
implementing efficient processes and undertaking process improvement [20].   Previously this was 
not a critical issue due to the limited proportion of software in medical devices and it was acceptable 
to take a compliance centric approach.  This is no longer the case and there is now a particular 
requirement for highly effective and efficient software development processes to be in place.  These 
processes need to be defined in a regulatory compliant manner and then adopted to produce the 
required deliverables in order to achieve approval [19]. To address this requirement Medi SPICE [21], 
a medical device software process assessment and improvement model is currently under 
development and is discussed in section 2.  While there is a specific requirement for Medi SPICE 
which is  a comprehensive and detailed model there is also industry demand  for  lightweight 
medical device software process assessment methods [22].   Medi SPICE-Adept has been developed 
to help address this requirement and this is discussed in section 3 along with the procedure for its 
implementation.    Section 4 outlines how a Medi SPICE-Adept assessment was undertaken and 
provides a summary of the process improvement plan which was collaboratively developed based on 
the findings report. Section 5 provides a summary and context for future work based on this 
research.  
 2 Medi SPICE 
Existing generic Software Process Improvement (SPI) models are available which include the  
Capability Maturity Model Integration (CMMI®) [23] and  ISO 15504-5:2006 [24] (SPICE), but these 
were not developed to provide sufficient coverage of all of the necessary areas required to achieve 
medical device regulatory compliance [25].  To address the requirement for a medical device 
software process assessment and improvement model the Regulated Software Research Group 
(RSRG) at Dundalk Institute of Technology (DkIT) undertook extensive research in the area [19]. This 
resulted in work commencing on the development of Medi SPICE a medical device specific software 
process assessment and improvement model which is being developed in collaboration with the 
SPICE User Group.  This approach is in line with that taken for the development of Automotive SPICE 
[26]  which is a software process assessment and improvement model which is domain specific to 
the automotive industry.  
 
Medi SPICE is based upon the latest version of ISO/IEC 15504-5 (currently under ballot)  and  ISO/IEC 
12207:2008 [27].  It also provides coverage of the relevant medical device regulations, standards, 
technical reports and guidance documents. These include IEC 62304:2006 and its aligned standards, 
the FDA regulations [28]  and guidance documents and the European MDD and guidelines. The 
objective of undertaking a Medi SPICE assessment is to determine the state of a medical device 
organisation’s software processes and practices in relation to the regulatory requirements of the 
industry  and to identify areas for process improvement [29]. It can also be used as part of the 
supplier selection process when an organisation wishes to outsource or offshore part or all of their 
medical device software development to a third party or remote division [30].  
 
Medi SPICE contains a Process Reference Model (PRM) which consists of forty two processes and 
fifteen subprocesses which are fundamental to the development of regulatory compliant medical 
de-vice software.  Each process has a clearly defined purpose and outcomes that must be 
accomplished to achieve that purpose. Medi SPICE also contains a Process Assessment Model (PAM) 
which is related to the PRM and forms the basis for collecting evidence and the rating of process 
capability. This is achieved by the provision of a two-dimensional view of process capability. In one 
dimension, it describes a set of process specific practices that allow the achievement of the process 
outcomes and purpose defined in the PRM; this is termed the process dimension.  In the other 
dimension, the PAM describes capabilities that relate to the process capability levels and process 
attributes, this is termed the capability dimension. 
 
In line with ISO/IEC 15504-2:2003 [31]  Medi SPICE process capability is defined over 6 levels:  
• Level 0 Incomplete; 
• Level 1 Performed; 
• Level 2 Managed; 
• Level 3 Established; 
• Level 4 Predictable; 
• Level 5 Optimizing. 
  
The Medi SPICE PRM and PAM are being released in stages and each stage is extensively reviewed by 
interested parties from the SPICE User Group, representatives from international standards bodies 
and industry experts.  This collaborative approach is seen as a key element in the development of 
Medi SPICE to ensure coverage of both the SPI and medical device software regulatory requirements 
[29].  Medi SPICE is a comprehensive and detailed model and its overall objective is to provide a 
conformity assessment scheme to support first, second or third party assessments. It is envisaged 
that results from these assessments may be recognized by the relevant regulatory bodies.  
 
 
3 Medi SPICE-Adept 
As outlined in section two there is a specific requirement for a detailed and comprehensive process 
assessment and improvement model which is specific to the medical device domain which Medi 
SPICE is being developed to address.  As with other SPI assessments models i.e. CMMI® and IEC 
15504-5:2006 a full Medi SPICE assessment will require considerable planning and resources to suc-
cessfully undertake.  While Medi SPICE is being developed with the objective of being as efficient as 
possible the necessity for rigour dictates the level of planning, resources and analysis required for its 
successful implementation. While the need for and importance of Medi SPICE is understood [21], it 
was also appreciated by the RSRG that there is a  specific  requirement for lightweight assessment 
methods in the medical device software industry [32].  In particular there was industry led demand 
for a lightweight assessment method based on Medi SPICE. This was communicated directly to the 
RSRG by numerous medical device organisations. To address this specific requirement Medi SPICE-
Adept was developed.  There were two additional objectives in undertaking this task.  The first was 
the opportunity to leverage the extensive research [19] and level of detail which developing Medi 
SPICE provided. The second was the opportunity to identify and facilitate the use of agile and lean 
methods for medical device software development. The use of agile and lean methods in this 
context is an area that the RSRG are also currently researching to assist organisations increase the 
efficiency of their software development practices  [33]. 
 
To be effective Medi SPICE-Adept required the employment of a lightweight approach for 
undertaking   software process assessment and improvement. This included the use of a limited 
number of personnel to carryout and participate in the assessment while also maximising the benefit 
of the time and effort of those involved. It was envisaged that Medi SPICE-Adept would eventually 
encompass all the Medi SPICE processes. It was therefore recognized that an assessment could take 
place over a day or a number of days depending on how many processes were being assessed. It was 
also important that organisations could select the specific processes which were of most benefit for 
achieving their business goals.  The focus of the method had to be on the evaluation of the essential 
practices, key work products and the achievement of the outcomes which were necessary for the 
attainment of the specific process purpose being assessed.  Medi SPICE-Adept therefore needed to 
be process dimension centric in its focus.  Finally the objective of undertaking a Medi SPICE-Adept 
assessment was not to receive formal certification or a rating, but rather to identify an 
organization’s strengths and weaknesses and to facilitate process improvement. Having defined the 
criteria which had to be met the next step was to undertake the development of Medi SPICE-Adept.  
 
3.1 Developing Medi SPICE-Adept 
The RSRG having previously successfully developed and implemented three lightweight software 
process assessment methods Adept [34], Med-Adept [35] and Med-Trace [36]  the objective was to 
leverage that experience and utilise it for the development of Medi SPICE-Adept.  It was in this 
context that work commenced on the development of Medi SPICE-Adept.  It was recognized that this 
assessment method needed to cover more processes and provide more detailed analysis than those 
methods which had been previously developed.   While this was the case Medi SPICE-Adept was still 
required to be lightweight to fulfil its purpose.  The first task was to identify the initial Medi SPICE 
processes that would be utilised. The goal was to select a limited number of processes that would be 
most beneficial and relevant to industry.  To achieve this, industry experts were consulted and ten 
processes were selected: 
• Requirements Elicitation; 
• System Architectural design; 
• Systems Requirements Analysis;  
• Software Requirements Analysis,  
• Software Construction;  
• Software Integration;  
• Software Testing; 
• Configuration Management; 
• Change Request Management;  
• Verification. 
While these were the initial processes selected Medi SPICE-Adept will provide coverage of all the 
Medi SPICE processes and subprocesses.   
 
The Medi SPICE PAM had been developed for each of the initial processes which were based on best 
practice as outlined by the latest version of ISO/IEC 15504-5 and the specific requirements of the 
medical device regulations, standards, technical reports and guidance documents. As a result each 
process had a defined purpose and outcomes, specific practices and work products were also 
included for the achievement of these outcomes and purpose.  In addition each outcome and 
specific practice was cross referenced to the regulations, standards etc. on which it was based. To 
facilitate the assessment each of the initial processes were evaluated and specific questions 
identified based on the Medi SPICE PAM.  In addition questions on the current or potential use of 
agile and lean methods were also identified and included. This work was undertaken by five 
members of the RSRG team with extensive experience of SPI and knowledge of medical device 
software development and included two experts in the area of lean and agile methods. Having 
defined the assessment instrument the next step was to develop the specific procedure for 
undertaking a Medi SPICE-Adept assessment. 
 
3.2 The Procedure for Undertaking a Medi SPICE-Adept Assessment 
Based on the RSRG’s previous experience of developing and undertaking lightweight software 
process assessments [32] the seven stage procedure for undertaking a Medi SPICE-Adept 
Assessment was defined. It was decided the assessment team should normally consist of two 
assessors who share responsibility for conducting the assessment. The seven stages of the 
procedure are as fol-lows:   As a precursor to undertaking an assessment a preliminary meeting 
between the lead assessor and the company takes place. This is the first stage in the procedure and 
during this meeting the lead assessor discusses the main drivers for the company wishing to 
undertake an assessment.  In this context the expectations regarding what can be realistically 
achieved are discussed and the procedure for undertaking the assessment is outlined.  If there is 
agreement a schedule is drawn up.   At the second stage the lead assessor has a meeting with the 
staff and management from the company who will be participating in the assessment where an 
overview of the Medi SPICE-Adept assessment method is presented and details of what their 
participation will involve is outlined.  On the agreed date the onsite assessment commences which is 
the third stage in the procedure.  For each process the lead assessor conducts interviews based on 
the scripted Medi SPICE-Adept questions with the relevant personnel and evaluates the responses. 
The second assessor who also participates in the interviews prepares interview notes and may ask 
additional questions when clarification is required.   In addition work products may also be 
requested and briefly reviewed as part of this stage.   A maximum of five processes are assessed in a 
single day with the interviews for each process taking approximately one hour. At the fourth stage 
the findings report is prepared off site based on the data gathered at stage three.  Each process is 
reviewed in turn and where relevant particular strengths and issues (weaknesses) are identified 
based on the evaluation and interview notes.  Suggested actions to address these issues and to 
facilitate process improvement are outlined and discussed.  The possibility for the use of appropriate 
agile and lean practices is also considered.  These are then documented and included in the findings 
report.  This is a joint effort between the assessors and may include other SPI and/or lean and agile 
experts if required. The findings report is then presented to the management and staff who took 
part in the assessment which is the fifth stage in the procedure.  Having provided adequate time for 
the findings report to be read and considered by the organization at the sixth stage the contents of 
the report is discussed in detail with the relevant management and staff.  At this point specific 
objectives for process improvement are collaboratively defined based on the findings report which 
results in the development of a process improvement plan.  Given the lightweight nature of Medi 
SPICE-Adept improvements that offer the greatest benefits in terms of compliance, quality and the 
achievement of business goals are selected for inclusion in this plan.  At the seventh stage in the 
procedure the organisation having implemented the process improvement plan have the 
opportunity of having the processes reassessed. Based on this, a final detailed report is prepared 
which highlights what has been achieved and an updated improvement plan is also provided. 
 
 
4 Implementation of a Medi SPICE-Adept Assessment  
Having developed the Medi SPICE-Adept Assessment method and the procedure for its 
implementation  the first assessment took place in an Irish based medical device company Western 
Medical (a pseudonym).  The company have been developing and selling medical devices for over 
thirty years.  Each of their products contains both hardware and software and the role that software 
plays has considerably increase over the last number of years.  They market their medical devices in 
the EU and the US so their products must conform to the MDD to receive the CE mark and the FDA 
regulations.  Having agreed that an assessment would take place it was decided that the ten 
processes would be assessed over a two day period. This was undertaken by two assessors from the 
RSRG. Based on the results of the assessment a findings report was prepared and presented. The 
focus of the report was that for each process the company’s strengths and issues were highlighted, 
in addition suggested actions to facilitate process improvement were also provided.  Based on the 
findings report the process improvement objectives and process improvement plan were 
collaboratively defined and developed with the company.  A summary of the issues identified for 
each process and the actions taken to address these issues and facilitate improvement were 
outlined in the process improvement plan as follows: 
 
Requirements Elicitation - A serious problem which emerged from the assessment was that the re-
quirements specification produced was too high level.  It did not capture the level of detail required 
to facilitate product development and both the hardware and software engineers had to try to guess 
what some of the specific requirements were. Marketing took the place of the company’s customers 
and would not commit on their exact requirements.  To address this, the use of prototyping and user 
scenarios to define key product features to facilitate the development of a detailed and 
comprehensive requirements specification was agreed. Senior Management support was also sought 
to reinforce the importance of ensuring marketing’s full participation in defining and signing off on 
requirements.   
 
Systems Requirements Analysis - The need for a systems requirements specification document was 
identified and this was an important omission as it was also necessary for traceability.   The high 
level requirements specification was used in this process and it was not adequate as it lacked the 
necessary level of detail. In addition system requirements were not prioritised.  It was agreed that a 
systems requirement specification would be developed based on the detailed requirements 
specification and that system requirements would be prioritised.  
 
Configuration Management – While a configuration management tool was in place some key work 
products were not under configuration management and for those that were some important 
information was missing.  In addition key features of the tool i.e. automatic merging was not being 
used.  It was agreed that a configuration management strategy would be drawn up and 
implemented that ensured all the relevant work products were correctly managed and that the 
required level of detail was maintained.  It was also agreed that all the relevant features of the tool 
would be updated and utilised.   
 
Change Request Management - An ad-hoc change request management system was in place as a 
result requests were not prioritised, the level of detail provided was limited and the status of 
accepted change requests could not be determined until they were complete.  To address these 
issues it was agreed that a formal change request management strategy would be developed and 
implemented.  The selection of a tool to assist with this process would also be investigated.   .  
 
System Architectural Design - This process was dealt with in a very informal manner and a system 
architectural design specification was not produced. The IEC 62304:2006 requirement for a safety 
classification of each product was not addressed. This omission was important as this standard is 
now harmonized with the MDD and approved by the FDA.  It was recommended and agreed that a 
formal system architectural design process would be put in place to facilitate the production of a 
system architectural design specification and to ensure that each product receives the relevant 
safety classification. 
 
Software Construction - There was no defined strategy in place for performing unit testing. As a 
result it was carried out in an ad-hoc manner as the content and level of testing was left to the 
discretion of the individual tester. Documentation was not maintained and therefore test cases and 
results were not recorded.  To address these issues it was agreed that a unit test strategy and 
procedures would be developed and implemented to ensure the required level of unit test coverage 
would be consistently provided and all unit test cases and results would be recorded.  
 
Software Integration - There was no defined strategy for performing software integration or a docu-
mented integration plan. This process was therefore performed in an informal manner and the 
content and level of testing was left to the discretion of the individual tester.  It was proposed and 
agreed that a software integration strategy should be developed and a software integration plan 
defined. The integration test procedures should be evaluated for correctness and completeness and 
they should be consistently implemented.  Integration test cases and test results should also be 
documented and recorded.  
 
Software Testing - Specific software testing did not take place after software integration. The next 
tests undertaken were on the complete system which incorporated both hardware and software.   
The need for a software testing process was discussed and agreed in the light of the requirements of 
the medical device standards and in line with best practice.  It was therefore proposed that a 
software testing strategy and procedures should be developed and implemented and test cases and 
results documented and recorded.  
 
Verification - In general there were good verification procedures in place. One issue highlighted by 
the assessment was that code reviews were only performed very late in the process. To address this, 
it was agreed that code reviews would take place prior to unit testing. 
 
The findings report was positively received by Western Medical as was the whole assessment proce-
dure.  The collaborative nature of the development of the process improvement plan provides 
motivation for its successful implementation.  The plan is currently being implemented and when 
this is complete the opportunity to have the processes reassessed is available. While in this paper we 
have focused on the negative issues we identified the company had very good risk management and 
trace-ability procedures in place.  It is important to state that Medi SPICE-Adept highlights the 
strengths as well as the weaknesses in an organization.   
 
 
5 Conclusion  
It is important to stress what the differences will be between a Medi SPICE assessment and Medi 
SPICE-Adept.  Medi SPICE is a comprehensive and detailed domain specific process assessment and 
improvement model for medical device software development. When the model is complete a Medi 
SPICE assessment method will be developed which will facilitate in-depth analysis and assess-ment 
of each process and this will include the determination of its capability level. As a result the findings 
from a Medi SPICE assessment will be extensive, comprehensive and detailed.  On the other hand 
Medi SPICE-Adept which is also based on the Medi SPICE model has a different purpose it is a 
lightweight assessment method. Its focus is more high level and its role is to provide a snap shot of 
key aspects of medical device software development processes and to assist with regulatory compli-
ance and process improvement in this context.   
 
Medi SPICE-Adept is the largest and most detailed lightweight assessment method developed by the 
RSRG.  It is the result of industry demand and was developed to meet the requirement from a more 
extensive, but lightweight medical device software assessment method.  A Medi SPICE-Adept as-
sessment has recently been successfully implemented in Australia by our colleagues in Griffith Uni-
versity.  Feedback from the Australian assessment was very positive and a specific request was that 
we include additional project management processes.  This is in line with our strategy for Medi 
SPICE-Adept and we plan to incorporate the remaining thirty two Medi SPICE processes and twelve 
subprocesses in the coming year.  Given the level of demand it is also our objective to carry out 
additional Medi SPICE-Adept assessments both in Ireland and in collaboration with our international 
colleagues.  
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